トップページ › フォーラム › 質問掲示板(FAQ) › Shu 1 Tiyp Mbd
- このトピックは空です。
-
投稿者投稿
-
Xvoaij
ゲストImportant reminder: while statins are effective, lifestyle modification remains the cornerstone of cardiovascular prevention. – https://gelnagels.startpalace.nl/ , The section on wearable technology for arrhythmia detection is particularly relevant. .
Wpupke
ゲストInformative article on Alzheimer’s prevention. The focus on modifiable risk factors such as hearing loss and social isolation is particularly noteworthy. – https://restaurantegurea.es/farmacia-fanabe-playa/ , Strong evidence for the benefits of physical activity in mental health. Exercise prescription should become standard in psychiatric care. .
Orpzry
ゲストAccurate summary of current TAVI indications and outcomes in aortic stenosis. – https://www.local.ch/it/d/melano/6818/fisioterapia/fisioterapia-bios-gf13XeBFNXoc171T-X5mTg , This review effectively summarizes current guidelines for anticoagulation in atrial fibrillation. DOACs have truly transformed patient care. .
Eavfqy
ゲストStrong case made for universal screening for gestational diabetes. – https://telindex.ch/?pg=su&obj=945922 , Important data on long COVID cognitive symptoms. Multidisciplinary clinics should be established more widely. .
Apapqk
ゲストElegant demonstration of how machine learning can predict acute kidney injury earlier than traditional methods. Implementation science is the next step. – http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817-74332014000100004 , Great summary of the latest lipid guidelines and when to consider PCSK9 inhibitors. .
Pvmicl
ゲストThis review effectively covers the expanding role of CDK4/6 inhibitors in breast cancer. – https://de.itsbetter.com/search/show/1211620-hospital-abc.html , The piece on cognitive behavioral therapy for insomnia is evidence-based and practical. .
Xnfcoo
ゲストGenetic testing for hereditary cancer syndromes should be offered more broadly based on family history. – https://mail.dewtreats.com/index.php/21st-ave-animal-clinic-astoria-vet-clinic-services-929 , The reported survival benefit in adjuvant immunotherapy for melanoma is impressive. Cost-effectiveness analyses in different healthcare systems are needed. .
-
投稿者投稿
